Intrinsic Value of S&P & Nasdaq Contact Us

Sientra, Inc. SIEN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
39/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sientra, Inc. (SIEN) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 38/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
90/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
65/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SIEN

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-10.27
Book Value / Share$0.00
Revenue / Share$12.62
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2013 $-20.90 $35.17M $-19.13M -54.4%
2014 $-22.80 $44.73M $-5.81M -13%
2015 $-26.14 $38.11M $-41.23M -108.2%
2016 $-22.03 $20.73M $-40.17M -193.7%
2017 $-33.42 $36.54M $-64.03M -175.2%
2018 $-32.50 $68.13M $-82.63M -121.3%
2019 $-26.30 $83.7M $-106.82M -127.6%
2020 $-17.90 $55M $-89.95M -163.5%
2021 $-11.00 $80.68M $-62.52M -77.5%
2022 $-10.27 $90.55M $-73.31M -81%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message